Pulse Biosciences (PLSE) Return on Capital Employed (2016 - 2025)
Pulse Biosciences' (PLSE) quarterly Return on Capital Employed came in at 75.33% in Q3 2025, up 556.0% year-on-year from 11.48% in Q3 2024, and down 22.88% quarter-over-quarter from 61.3% in Q2 2025.
Pulse Biosciences (PLSE) Return on Capital Employed (2016 - 2025) Analysis & Trends
Pulse Biosciences' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 75.33% for Q3 2025.
- On a quarterly basis, Return on Capital Employed rose 556.0% year-over-year to 75.33% in Q3 2025; TTM through Sep 2025 was 75.33%, a 556.0% increase from a year earlier, with the FY2025 full-year figure at 183.8%, up 24940.0% from the prior year.
- Return on Capital Employed declined to 75.33% in Q3 2025 per PLSE's latest filing, from 61.3% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 50.88% in Q1 2025 and bottomed at 187.59% in Q2 2022.
- The 5-year median for Return on Capital Employed is 80.89% (2024), against an average of 92.18%.
- Across the five-year window, Return on Capital Employed tumbled 10244 bps in 2022 and soared 11797 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 111.64% in 2021, then soared by 32 bps to 75.65% in 2022, then retreated by 3 bps to 78.03% in 2023, then climbed by 30 bps to 54.78% in 2024, then slumped by 38 bps to 75.33% in 2025.
- Per Business Quant, the three latest PLSE Return on Capital Employed figures stand at 75.33% (Q3 2025), 61.3% (Q2 2025), and 50.88% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.18 Bn | 121.97 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn | 5.02% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | 28.56% |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.34 Bn | 27.68 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 23.37 Bn | 22.94 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 14.11 Bn | 13.54 Bn | 1.10 Bn | 19.44% |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | 4.68% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 12.74% |
| 10 | Pulse Biosciences | 2.22 Bn | 2.14 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -75.33% |
| Jun 30, 2025 | -61.30% |
| Mar 31, 2025 | -50.88% |
| Dec 31, 2024 | -54.78% |
| Sep 30, 2024 | -80.89% |
| Jun 30, 2024 | -118.78% |
| Mar 31, 2024 | -90.93% |
| Dec 31, 2023 | -78.03% |
| Sep 30, 2023 | -61.29% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -75.08% |
| Dec 31, 2022 | -75.65% |
| Sep 30, 2022 | -113.38% |
| Jun 30, 2022 | -187.59% |
| Mar 31, 2022 | -152.73% |
| Dec 31, 2021 | -111.64% |
| Sep 30, 2021 | -95.76% |
| Jun 30, 2021 | -85.15% |
| Mar 31, 2021 | -112.55% |
| Dec 31, 2020 | -137.68% |